Bio-Thera Solutions, Ltd. (SHA:688177)
China flag China · Delayed Price · Currency is CNY
16.16
-0.56 (-3.35%)
At close: Nov 16, 2026

Bio-Thera Solutions Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
307.97218.61289.8163.99165.94847.47
Trading Asset Securities
--90.22331.03629.89602.83
Cash & Short-Term Investments
307.97218.61380.02495.01795.831,450
Cash Growth
15.28%-42.47%-23.23%-37.80%-45.13%17.03%
Accounts Receivable
213.83164.7108.26148.7289.75103.32
Other Receivables
3.392.994.232.091.963.67
Receivables
217.21167.68112.5150.891.72106.99
Inventory
390.37312.42253.1231.23161.990.1
Other Current Assets
158.89259.84142.34133.36112.81123.08
Total Current Assets
1,074958.56887.951,0101,1621,770
Property, Plant & Equipment
1,1141,0711,0661,014693.91579.43
Long-Term Investments
15.5415.5515.710-21.1
Other Intangible Assets
279.09218.44224.1230.38234.18239.47
Long-Term Deferred Charges
3.173.683.52.01--
Other Long-Term Assets
54.8220.568.0919.8689.397.31
Total Assets
2,5412,2872,2062,2872,1802,618

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
213.3198.69199.49171.4583.7712.73
Accrued Expenses
66.67118.8188.5369.5167.4190.91
Short-Term Debt
54.980.0888.75105.40.0130.05
Current Portion of Long-Term Debt
299.97231.69169.450.21--
Current Portion of Leases
-0.06-3.183.492.38
Current Income Taxes Payable
8.1---0-
Current Unearned Revenue
974.09731.82545.33318.5374.08381.61
Other Current Liabilities
52.696.214.237.179.748.36
Total Current Liabilities
1,6701,3671,096725.42538.5526.04
Long-Term Debt
615.74374.21370.43323.843-
Long-Term Leases
----3.01-
Long-Term Unearned Revenue
21.424.9231.2925.1327.974.23
Other Long-Term Liabilities
191.59144.81----
Total Liabilities
2,4981,9111,4971,074572.48530.27

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
414.08414.08414.08414.08414.08414.08
Additional Paid-In Capital
3,0543,0543,0543,0543,0543,054
Retained Earnings
-3,425-3,092-2,766-2,256-1,861-1,381
Comprehensive Income & Other
-0.3-0.145.6800.01-0.13
Shareholders' Equity
42.94376.03708.091,2131,6072,088
Total Liabilities & Equity
2,5412,2872,2062,2872,1802,618

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
970.61686.04628.58482.629.5132.43
Net Cash (Debt)
-662.65-467.43-248.5612.39786.331,418
Net Cash Growth
----98.42%-44.54%14.41%
Net Cash Per Share
-1.59-1.13-0.600.031.903.46
Filing Date Shares Outstanding
414.08414.08414.08414.08414.08414.08
Total Common Shares Outstanding
414.08414.08414.08414.08414.08414.08
Working Capital
-595.3-408.8-207.78284.98623.761,244
Book Value Per Share
0.100.911.712.933.885.04
Tangible Book Value
-236.15157.59483.99982.341,3731,848
Tangible Book Value Per Share
-0.570.381.172.373.324.46
Buildings
-667.49291.95291.16281.63220.84
Machinery
-913.06663.05608.15569.52507.47
Construction In Progress
-47.24580.96505.21155.8395.04